| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $118.1M | +15.2% |
| SG&A Expense | $26.0M | +10.2% |
| Operating Income | -$144.1M | -14.2% |
| Income Tax | $0 | — |
| Net Income | -$138.4M | -18.1% |
| EPS (Basic) | -$3.83 | -11.3% |
| EPS (Diluted) | -$3.83 | -11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.3M | -67.0% |
| Current Assets | $68.3M | -61.9% |
| Total Assets | $79.9M | -60.0% |
| Current Liabilities | $21.7M | -5.2% |
| Total Liabilities | $28.4M | -7.6% |
| Stockholders' Equity | $51.6M | -69.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.9M | -24.1% |
| Capital Expenditures | $362K | -89.3% |
| Investing Cash Flow | -$362K | +83.7% |
| Financing Cash Flow | $1.7M | -99.0% |
| Free Cash Flow | -$120.3M | -20.3% |